A new long-acting glucagon-like peptide-1 (GLP-1) analogue from Novo Nordisk for glycemic control in adults with type 2 diabetes who have received metformin and/or sulfonylureas in addition to diet control and exercise. And reduce the risk of major cardiovascular adverse events (cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke) in adults with type 2 diabetes with cardiovascular disease.
1. Who are we?
We are based in Henan, China, start from 2021,sell to North America(25.00%),Eastern Europe(15.00%),Mid East(15.00%),South America(10.00%),Eastern Asia(10.00%),Western Europe(10.00%),Central America(5.00%),Southeast Asia(3.00%),Africa(2.00%),Northern Europe(2.00%),Southern Europe(2.00%),Oceania(1.00%). There are total about 51-100 people in our office.
2. How can we guarantee quality?
Always a pre-production sample before mass production;
Always final Inspection before shipment;
3.What can you buy from us?
,PDO Thread,Liporase,Micro Cannula,dermal filler,numbing cream,etc
4. What services can we provide?
Accepted Delivery Terms: FOB,CFR,CIF,EXW,FAS,CIP,FCA,CPT,DEQ,DDP,DDU,Express Delivery,DAF,DES;
Accepted Payment Currency:USD,EUR,JPY,CAD,AUD,HKD,GBP,CNY,CHF;
Accepted Payment Type: T/T,L/C,D/P D/A,MoneyGram,Credit Card,PayPal,Western Union,Cash,Escrow;
Language Spoken:English,Chinese,Spanish,Japanese,Portuguese,German,French,Russian,Korean,Hindi,Italian
